Brief Case

Treas. Reg. § 54.9825-4T

Reporting requirements related to prescription drug and health care spending (temporary).
eCFR amendment effective 2021-11-23 · superseded Dec 23, 2021
Back to current
Historical text in effect Nov 23, 2021 through Dec 22, 2021. View current · Compare with current
Link to an amendment published at 86 FR 66696, Nov. 23, 2021.
Treas. Reg. § 54.9825-4T — Reporting requirements related to prescription drug and health care spending (temporary). · eCFR amendment effective 2021-11-23 · https://pensionresource.website/EAMain?content=EAMain.Law&id=cfr26-54.9825-4T&asof=2021-11-23 · printed Oct 16, 2026
Cited by (code & regs)
Guidance addressing this section
IRS / Treasury
Treasury Decisions
  • T.D. 9958 Dec 6, 2021 — This document sets forth temporary regulations implementing certain transparency requirements under section 204 of Division BB of Title II of the Consolidated … (a)(b)(c)(d)(1)(d)(2)
Also cited in 2 other documents
IRS / Treasury
Proposed Rules
  • 86 FR 66495Proposed Nov 23, 2021 — Prescription Drug and Health Care Spending Comments due Jan 24, 2022
Final Rules

No court rulings in the library cite this provision yet.

No private letter rulings in the library cite this provision yet.

Each row is a version of the text as published by the official source. Code dates are the edition/release point that first reflected the change; regulation dates are eCFR effective dates. The library checks the official sources automatically, so new versions appear here on their own; “run” opens the sync that recorded a version.

EffectiveThroughSourceAmended by
Nov 23, 2021Dec 22, 2021eCFR amendment effective 2021-11-23 run 6View
Dec 23, 2021currenteCFR editorial change effective 2021-12-23 run 6T.D. 9958, 86 FR 66696, Nov. 23, 2021View · Redline (sign in)
Provision-level history (blame)